about
Oncogenic microRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serumMiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia.Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas.Prediction Potential of Serum miR-155 and miR-24 for Relapsing Early Breast Cancer.Somatic mutation dynamics in MDS patients treated with azacitidine indicate clonal selection in patients-responders.Metformin Treatment for Diabetes Mellitus Correlates with Progression and Survival in Colorectal Carcinoma
P50
description
researcher
@en
name
Michal Pesta
@en
type
label
Michal Pesta
@en
prefLabel
Michal Pesta
@en
P31
P496
0000-0001-5311-0797